Loading…
CIK 0001381843 • 6 13F filings • May 5, 2025 – Jul 24, 2026
Import this data to Google Sheets with:
=jivedata("atle-fund-management-ab","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| AbbVie Inc | COM | $24.7M | 7.9%Prev: 8.4% | 108,181 SH | Increased+16,076 SH |
| ABIVAX SA | SPONSORED ADS | $4.3M | 1.4% | 31,590 SH | New |
| Alkermes PLC | SHS | $6.8M | 2.2%Prev: 3.0% | 242,473 SH | Increased-10,402 SH |
| Amgen Inc | COM | $7.2M | 2.3%Prev: 1.5% | 21,903 SH | Increased+8,097 SH |
| Arcellx Inc | COMMON STOCK | $2.7M | 0.9%Prev: 0.8% | 41,717 SH | Increased+15,985 SH |
| Autolus Therapeutics PLC | SPON ADS | $2.3M | 0.7%Prev: 0.8% | 1,169,634 SH | Increased |
| BEONE MEDICINES LTD-ADR | SPONSORED ADS | $12.3M | 3.9% | 40,432 SH | New |
| BICARA THERAPEUTICS INC | COM | $1.9M | 0.6%Prev: 1.3% | 111,363 SH | Increased-92,392 SH |
| Boston Scientific Corp | COM | $10.4M | 3.3%Prev: 3.3% | 108,682 SH | Increased+22,002 SH |
| Bridgebio Pharma Inc | COM | $10.8M | 3.4%Prev: 3.6% | 141,296 SH | Increased-33,426 SH |
| Cardinal Health Inc | COM | $4.8M | 1.5%Prev: 1.9% | 23,470 SH | Increased-6,827 SH |
| CELCUITY INC | COM | $4.2M | 1.3%Prev: 0.7% | 41,831 SH | Increased+4,674 SH |
| Cencora Inc | COM | $8.0M | 2.6%Prev: 3.5% | 23,773 SH | Increased-4,835 SH |
| COMPASS THERAPEUTICS INC | COM | $3.1M | 1.0% | 584,332 SH | New |
| Corbus Pharmaceuticals Holding | COM | $873K | 0.3%Prev: 0.9% | 107,255 SH | Increased-68,327 SH |
| CVS HEALTH CORP | COM | $8.5M | 2.7% | 106,518 SH | New |
| Dexcom Inc | COM NEW | $2.6M | 0.8%Prev: 1.3% | 39,722 SH | Increased-11,150 SH |
| Disc medicine inc | COM | $3.8M | 1.2%Prev: 1.2% | 47,967 SH | Increased+2,277 SH |
| Eli Lilly & Co | COM | $33.5M | 10.7%Prev: 11.2% | 31,133 SH | Increased-6,111 SH |
| Gilead Sciences Inc | COM | $6.2M | 2.0%Prev: 3.4% | 50,796 SH | Increased-27,373 SH |
| IDEAYA BIOSCIENCES INC | COM | $3.4M | 1.1% | 97,438 SH | New |
| INCYTE CORP | COM | $7.0M | 2.2% | 70,851 SH | New |
| INSMED INC | COM PAR $.01 | $4.9M | 1.5% | 27,873 SH | New |
| Intuitive Surgical Inc | COM NEW | $12.6M | 4.0%Prev: 3.5% | 22,322 SH | Increased+2,615 SH |
| IONIS PHARMACEUTICALS INC | COM | $7.3M | 2.3% | 92,377 SH | New |
| iRhythm Technologies Inc | COM | $6.7M | 2.1%Prev: 2.0% | 37,579 SH | Increased+7,588 SH |
| Krystal Biotech, Inc | COM | $8.3M | 2.7%Prev: 2.9% | 33,853 SH | Increased-8,338 SH |
| Merck & Co. Inc | COM | $20.6M | 6.6%Prev: 5.3% | 195,768 SH | Increased+34,855 SH |
| Mirum Pharmaceuticals Inc | COM | $7.1M | 2.3%Prev: 2.7% | 89,685 SH | Increased-3,920 SH |
| Neurocrine Biosciences Inc | COM | $13.4M | 4.3%Prev: 5.7% | 94,796 SH | Increased-7,829 SH |
| NewAmsterdam Pharma Co NV | ORDINARY SHARES | $6.9M | 2.2%Prev: 2.2% | 197,036 SH | Increased+3,411 SH |
| PYXIS ONCOLOGY INC | COMMON STOCK | $710K | 0.2% | 617,245 SH | New |
| REVOLUTION Medicines Inc | COM | $7.2M | 2.3%Prev: 1.6% | 90,184 SH | Increased+4,829 SH |
| Soleno Therapeutics Inc | COM | $2.9M | 0.9%Prev: 1.6% | 62,735 SH | Increased+2,579 SH |
| Stryker Corporation | COM | $9.4M | 3.0%Prev: 3.3% | 26,835 SH | Increased+4,066 SH |
| Thermo Fisher Scientific Corp | COM | $17.3M | 5.5%Prev: 5.2% | 29,915 SH | Increased+2,768 SH |
| UFP Technologies Inc | COM | $5.1M | 1.6%Prev: 1.8% | 22,986 SH | Increased |
| Universal Health Services Inc | COM | $3.2M | 1.0%Prev: 1.1% | 14,636 SH | Increased+909 SH |
| Vertex Pharmaceuticals Inc | COM | $10.4M | 3.3%Prev: 2.7% | 22,984 SH | Increased+5,218 SH |
| 13F-HR |
| 0001381843-26-000005 |
| $371.7M |
| View |
| Jul 14, 2025 | Q2 2025 | 13F-HR | 0001381843-25-000006 | $233.7M | View |
| May 11, 2026 | Q1 2026 | 13F-HR | 0001381843-26-000004 | $309.7M | View |
| May 5, 2025 | Q1 2025 | 13F-HR | 0001381843-25-000004 | $226.5M | View |